Trial Profile
Clinical Trials Insight: 700015298
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 27 Sep 2006
Price :
$35
*
At a glance
- Drugs Talotrexin (Primary)
- Indications Gastric cancer; Solid tumours
- Focus Adverse reactions
- 27 Sep 2006 New trial record.